Cite

    Bader, M. S., Someili, A., Alosali, A., Hadzic, A., Irfan, N., Leto, D., Mertz, D., & Brooks, A. A. (2021). high-Dose Oral Vancomycin for Treatment of Clostridioides difficile Is Associated With High Risk of Subsequent Cultures With Gram-Negative Organisms. Infectious diseases in clinical practice, 29(6), e361–e365. http://access.bl.uk/ark:/81055/vdc_100173686702.0x00000d